1. 1) Selkoe DJ. Alzheimer’s disease: genes, proteins, and therapy. Physiol. Rev., 81, 741–766 (2001).
2. 2) Lorenzo A, Yankner BA. β-Amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proc. Natl. Acad. Sci. U.S.A., 91, 12243–12247 (1994).
3. 3) Martin JB. Molecular basis of the neurodegenerative disorders. N. Engl. J. Med., 340, 1970–1980 (1999).
4. 4) Hardy JA, Higgins GA. Alzheimer’s disease: the amyloid cascade hypothesis. Science, 256, 184–185 (1992).
5. 5) Lambracht-Washington D, Rosenberg RN. Advances in the development of vaccines for Alzheimer’s disease. Discov. Med., 15, 319–326 (2013).